SBIA
BIIB icon

Sheaff Brock Investment Advisors’s Biogen BIIB Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-710
Closed -$201K – 549
2021
Q3 		$201K Hold
710
– – 0.01% 494
2021
Q2 		$246K Sell
710
-60
-8% -$18.2K 0.02% 415
2021
Q1 		$215K Buy
+770
New +$208K 0.02% 425
2020
Q4 		– Sell
-910
Closed -$258K – 489
2020
Q3 		$258K Hold
910
– – 0.02% 334
2020
Q2 		$243K Buy
910
+21
+2% +$6.31K 0.02% 347
2020
Q1 		$281K Sell
889
-100
-10% -$30.3K 0.04% 280
2019
Q4 		$293K Sell
989
-350
-26% -$97.1K 0.03% 342
2019
Q3 		$312K Sell
1,339
-50
-4% -$11.6K 0.03% 327
2019
Q2 		$325K Sell
1,389
-350
-20% -$80.8K 0.03% 323
2019
Q1 		$411K Sell
1,739
-150
-8% -$47.2K 0.05% 284
2018
Q4 		$568K Sell
1,889
-600
-24% -$191K 0.09% 209
2018
Q3 		$879K Sell
2,489
-20
-0.8% -$6.89K 0.08% 179
2018
Q2 		$728K Hold
2,509
– – 0.07% 196
2018
Q1 		$687K Sell
2,509
-127
-5% -$39.4K 0.07% 202
2017
Q4 		$840K Sell
2,636
-170
-6% -$54.5K 0.11% 180
2017
Q3 		$879K Sell
2,806
-60
-2% -$17.8K 0.12% 170
2017
Q2 		$778K Hold
2,866
– – 0.1% 205
2017
Q1 		$784K Buy
2,866
+75
+3% +$21.2K 0.1% 199
2016
Q4 		$791K Sell
2,791
-275
-9% -$81.5K 0.1% 211
2016
Q3 		$959K Sell
3,066
-2,759
-47% -$817K 0.13% 153
2016
Q2 		$1.41M Buy
5,825
+2,615
+81% +$689K 0.18% 119
2016
Q1 		$836K Buy
3,210
+41
+1% +$10.8K 0.1% 192
2015
Q4 		$971K Buy
+3,169
New +$911K 0.11% 184

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Sheaff Brock Investment Advisors's BIIB Position: Q4 2021 in Review

Sheaff Brock Investment Advisors sold out of Biogen (BIIB) in Q4 2021, closing a stake of 710 shares — an estimated $201K sold.

Sheaff Brock Investment Advisors first reported a position in BIIB in Q4 2015 and held it in 23 quarters. The position peaked at $1.41M in Q2 2016. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Sheaff Brock Investment Advisors reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 710 Biogen shares in Q4 2021, an estimated $201K.
  • Sheaff Brock Investment Advisors first reported a position in Biogen in Q4 2015 and held it in 23 quarters.
  • Sheaff Brock Investment Advisors's Biogen position peaked at $1.41M in Q2 2016.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Sheaff Brock Investment Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.